Moreover, HMSN-ISO@ProA-PDL1 Ab exhibited the strongest inhibitory ability at 48 h, possibly due to the targeted binding effect of PD-L1 Ab in nanoparticles with PD-L1 receptors of tumor cells (Fig. 7H and I). The gene discussed is CD274; the disease is neoplasm.